[HTML][HTML] Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. pathogenic effectors and novel therapeutic targets?
E Cavalli, R Ciurleo, MC Petralia, P Fagone, R Bella… - Molecules, 2020 - mdpi.com
Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
E Cavalli, R Ciurleo, MC Petralia, P Fagone, R Bella… - Molecules, 2020 - cir.nii.ac.jp
抄録< jats: p> Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite
the current available multiple therapeutic options, the prognosis for high-risk NB patients …
the current available multiple therapeutic options, the prognosis for high-risk NB patients …
[PDF][PDF] Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
E Cavalli, R Ciurleo, MC Petralia, P Fagone, R Bella… - …, 2020 - scienceopen.com
Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
[PDF][PDF] Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
E Cavalli, R Ciurleo, MC Petralia, P Fagone… - …, 2020 - pdfs.semanticscholar.org
Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
[HTML][HTML] Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
E Cavalli, R Ciurleo, MC Petralia, P Fagone, R Bella… - Molecules, 2020 - ncbi.nlm.nih.gov
Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
E Cavalli, R Ciurleo, MC Petralia… - Molecules (Basel …, 2020 - pubmed.ncbi.nlm.nih.gov
Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
E Cavalli, R Ciurleo, MC Petralia, P Fagone… - Molecules (Basel …, 2020 - europepmc.org
Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
E Cavalli, R Ciurleo, MC Petralia, P Fagone… - …, 2020 - iris.uniecampus.it
: Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
E Cavalli, R Ciurleo, MC Petralia, P Fagone… - …, 2020 - search.proquest.com
Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
E Cavalli, R Ciurleo, MC Petralia, P Fagone… - …, 2020 - search.ebscohost.com
Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …
available multiple therapeutic options, the prognosis for high-risk NB patients remains …